EU asks industry for comment on clarity of pricing/reimbursement decisions
This article was originally published in Scrip
The European Commission has launched a public consultation on how to improve the transparency of pharmaceutical pricing and reimbursement decisions by member states under the current EU rules.
You may also be interested in...
The international group of pharmaceutical inspectorates, PIC/S, has issued an aide-memoire and a Q&A document to support its 2018 guideline on using health-based exposure limits to assess the risk of cross contamination in shared manufacturing facilities.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-one guidance documents have been posted on the tracker since its last update.